Impact of a Multicomponent Exercise Program on Cognitive and Functional Outcomes in Patients With Mild Cognitive Impairment
NCT ID: NCT07334392
Last Updated: 2026-01-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
45 participants
INTERVENTIONAL
2025-12-01
2026-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does the innovative therapeutic exercise program improve gait and balance? Does the innovative therapeutic exercise program improve cognition?
Researchers will compare the innovative therapeutic exercise program emphasizing in dual-task exercises to a therapeutic exercise program without emphasizing in dual-task exercises and to a control group (given instruction about the benefits of exercise).
Participants will:
* Perform the exercise program twice a week for three months.
* Will be assessed before and after the intervention.
* Will record The Borg Scale of Perceived Exertion every second week to monitor and assess the progression of exercise intensity.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Pilot Study for Efficacy of Cognitive and Physical Training in Patients With Mild Cognitive Impairment
NCT06355973
Physical Training and Cognitive Activity on the Mild Cognitive Impairment (MCI) Patient
NCT01553929
Effects of Combined Physical-cognitive Training on Cognitive Function in MCI
NCT03805620
Brain Plasticity Following Aerobic Exercise in Patient With Mild Cognitive Impairment: Neuroimaging Study
NCT02114580
Dual-task Exercise in People With Cognitive Impairment
NCT06389812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Innovative therapeutic exercise program emphasizing in dual tasking
Participants will perform aerobic exercises, strengthening exercises and balance exercises combined with cognitive exercises at the same time for 60- 90 minutes/ twice a week/ three months.
Innovative therapeutic exercise program
Aerobic, strengthening and balance exercises combined with cognitive training -name: Experimental group 1 (EXP1)
Therapeutic exercise program
Participants will perform aerobic exercises, strengthening exercises and balance exercises for 60- 90 minutes/ twice a week/ three months.
Therapeutic exercise program
Aerobic, strengthening and balance exercises without cognitive training- name: Experimental group 2 (EXP2)
Control group
The control group will be provided with educational material in the form of a flyer outlining the health benefits of exercise and general lifestyle recommendations.
Flyer
The control group will receive only educational material in the form of a flyer, outlining the importance and potential benefits of physical activity, along with general lifestyle recommendations, without participating in the structured exercise intervention- name: Control group (CG)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Innovative therapeutic exercise program
Aerobic, strengthening and balance exercises combined with cognitive training -name: Experimental group 1 (EXP1)
Therapeutic exercise program
Aerobic, strengthening and balance exercises without cognitive training- name: Experimental group 2 (EXP2)
Flyer
The control group will receive only educational material in the form of a flyer, outlining the importance and potential benefits of physical activity, along with general lifestyle recommendations, without participating in the structured exercise intervention- name: Control group (CG)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* people with confirmed cognitive impairment, as evidenced by values within normal limits on the Montreal Cognitive Assessment test (MOCA ) \>20
* stable medication in the last month
* independent walking
Exclusion Criteria
* people suffering from chronic mental illness (e.g. schizophrenia, bipolar disorder)
* people suffering from a neurological disorder or injuries (e.g. multiple sclerosis, Parkinson's, traumatic brain injury)
* people with clinical depression (as determined by the Neuropsychiatric Inventory (NPI) assessment and medical diagnosis)
* people who have had recent surgery
* people with insufficient knowledge of the Greek language
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
General University Hospital of Patras
OTHER
Andreas Mentzelopoulos Foundation
UNKNOWN
University of Patras
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Eftychia Nastou
PhD candidate
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Physiotherapy, University of Patras
Pátrai, , Greece
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
17335/01-06-2025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.